CEL-SCI Announces Closing Of Public Offering For Gross Proceeds Of $6 Million

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM), a late-stage oncology company, today announced that it has closed an underwritten public offering of 7,894,737 shares of common stock and 1,973,684 warrants to purchase shares of common stock. For every four shares of common stock sold, we issued to investors in this offering one warrant to purchase a share of common stock. The common stock and warrants were sold at a combined price of $0.76 and resulted in aggregate gross proceeds of $6 million, prior to deducting underwriting commissions and offering expenses and excluding the exercise of any warrants. The common stock and warrants will separate immediately. The warrants are immediately exercisable, expire October 11, 2018, have an exercise price of $1.25 and trade on the NYSE MKT under the symbol “CVM WS”.

Help employers find you! Check out all the jobs and post your resume.